Medical/Pharmaceuticals
Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients
HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- During the 23th ERS International Congress onSeptember 11, Broncus announced long-term follow-up data about Bronchoscopic Thermal Vapor Ablation (BTVA) treatment using InterVapor®, the Company's product for the treatment of Chronic Obstructive Pulm...
2023-09-18 17:36
1966
Global Times: China's medical assistance boosts healthcare development in South Pacific region
BEIJING, Sept. 18, 2023 /PRNewswire/ -- "For this surgery, we have prepared for more than half a year," Xiao Yuehai told the Global Times when talking about the first laparoscopic surgery carried out inSolomon Islands. Xiao is an urologist from the Affiliated Hospital of Guizhou Medical Universi...
2023-09-18 17:13
1505
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series
HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total-Cap Index (LMSµ) and FTSE Global Micro Cap Index, according to the results o...
2023-09-18 14:51
3356
Peak Asia Pacific fertility body endorses reform blueprint to create more family friendly societies
ADELAIDE, Australia, Sept. 18, 2023 /PRNewswire/ -- A unique reform blueprint to advance family friendly policies and arrest falling birth rates will be championed across theAsia Pacific by the peak body representing scientists, doctors, nurses and counsellors in assisted reproduction in the regi...
2023-09-18 09:26
1595
Biotropics Malaysia Berhad Unveils Novel Brain Health Ingredient at Vitafoods Asia 2023
BANGKOK, Sept. 18, 2023 /PRNewswire/ -- September 20, 2023, Biotropics Malaysia Berhad, a leading producer of high-quality botanical extracts, is pleased to announce the launch of its novel BioKesum® leaf extract clinically shown to support brain health. BioKesum® leaf extract is sourced from the...
2023-09-18 08:00
1815
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today a new agreement with Bristol Myers Squibb (NYSE: BMY) for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung Biolog...
2023-09-18 07:57
1488
New drug class prevents key ageing mechanism in organ transplants
ATHENS, Greece, Sept. 18, 2023 /PRNewswire/ -- A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of ageing, in recipients of older donor organs. The pioneering research, presented today at the European Societ...
2023-09-18 06:01
1699
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection
GAITHERSBURG, Md., Sept. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...
2023-09-15 20:30
2321
MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP
HONG KONG, Sept. 15, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ("HKSTP"), the city's largest R&D base and one of the most important incubators. ...
2023-09-15 18:35
2446
Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000
ZURICH, Sept. 15, 2023 /PRNewswire/ -- Neoss Group, a leading innovator in
dental implant solutions, is proud to announce the fast and easy-to-use
wireless intraoral scanner, NeoScan™ 2000. This follows the success of last
year's launch of the NeoScan™ 1000.
2023-09-15 16:00
1975
Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023
SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2023 is pleased to honor 30 outstanding business leaders and enterprises for championing sustainable and responsible business practices. Presented by leading regional NGO Enterprise Asia, the AREA is the mo...
2023-09-15 11:37
1848
MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers
SINGAPORE, Sept. 15, 2023 /PRNewswire/ -- MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional gen...
2023-09-15 11:00
2618
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
GENEVA, Sept. 15, 2023 /PRNewswire/ -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimu...
2023-09-15 08:00
2069
Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease
REYKJAVIK, Iceland, Sept. 14, 2023 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and TheCopenhagen University, publish a study today in the journal Cell titled "Complex effects of sequence variants on lipid level...
2023-09-14 23:00
2294
Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases
SUZHOU, China and HONG KONG, Sept. 14, 2023 /PRNewswire/ -- Cure Genetics and Frametact Limited, a biotech company specializing in researching and developing treatments for neurological diseases, jointly announce the signing of a collaborative development and licensing agreement. The partnership ...
2023-09-14 23:00
1928
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease
PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application of ADEL-Y01 for the treatment of Alzheimer's disease (AD). Oscotec and ADEL are jointly developing ...
2023-09-14 20:00
1511
Porton Advanced and BRL Medicine Build Strategic Partnership to Accelerate Commercialization of Gene and Cell Therapies
SUZHOU, China, Sept. 14, 2023 /PRNewswire/ -- On September 13th, 2023, Porton Advanced Solutions (Porton Advanced) announced a strategic partnership with BRL Medicine Inc. (BRL Medicine). This collaboration will enhance the cell and gene therapy pipelines from BRL Medicine from clinical trials to...
2023-09-14 20:00
1908
Fujitsu and Baptist Health South Florida transform operating room scheduling with newly launched solution to boost utilization rates and the financial health of the surgical discipline
Recent trials with the solution delivered 37% improvement in available
prime-time minutes over a three-month period
TOKYO, Sept. 14, 2023 /PRNewswire/ -- Fujitsu today announced the launch of
an innovative solution to its Uvance Healthy Living
2023-09-14 18:03
1358
Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation"
Indonesian Minister of Health, Budi Gunadi Sadikin, emphasized that investing in the Health Technology and Biotechnology sector serves not only business prospects but also strengthens Indonesia's health resilience and adds value to healthcare. JAKARTA, Indonesia, Sept. 14, 2023 /PRNewswire/ -- F...
2023-09-14 17:47
1679
Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL
SHANGHAI, Sept. 14, 2023 /PRNewswire/ -- Dizal today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for golidocitinib for the treatment of relapsed or refractory peripheral T-cell lymphom...
2023-09-14 17:07
1558
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:492024 Malaysia E-Commerce Product Selection Expo Attracts International Delegations
[Picked up by 301 media titles]
2024-12-02 12:06
ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 284 media titles]
2024-11-29 20:33
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
7321
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5174